rs387906834
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_002241.5(KCNJ10):c.193C>T(p.Arg65Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R65P) has been classified as Pathogenic.
Frequency
Consequence
NM_002241.5 missense
Scores
Clinical Significance
Conservation
Publications
- EAST syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- Pendred syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- enlarged vestibular aqueduct syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002241.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNJ10 | NM_002241.5 | MANE Select | c.193C>T | p.Arg65Cys | missense | Exon 2 of 2 | NP_002232.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNJ10 | ENST00000644903.1 | MANE Select | c.193C>T | p.Arg65Cys | missense | Exon 2 of 2 | ENSP00000495557.1 | ||
| KCNJ10 | ENST00000638728.1 | TSL:5 | c.193C>T | p.Arg65Cys | missense | Exon 3 of 3 | ENSP00000492619.1 | ||
| KCNJ10 | ENST00000638868.1 | TSL:5 | c.193C>T | p.Arg65Cys | missense | Exon 3 of 3 | ENSP00000491250.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250710 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460696Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726370 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
EAST syndrome Pathogenic:3
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg65 amino acid residue in KCNJ10. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19420365). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this variant affects KCNJ10 protein function (PMID: 21849804). This variant has been observed in individual(s) with KCNJ10-related conditions (PMID: 21849804, 28835827). ClinVar contains an entry for this variant (Variation ID: 30251). This variant is present in population databases (rs387906834, ExAC 0.006%). This sequence change replaces arginine with cysteine at codon 65 of the KCNJ10 protein (p.Arg65Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at